-
TitleIndependent DirectorNameCheng, Wen-JungGenderMaleExperiences/EducationIndependent Director, SOE Co., Ltd.
Director, Fubo Co., Ltd.
Lead Accountant of Fubo CPAs
Professional Education Committee member, CPA Association ROC(Taiwan)
Master of Accounting, NTU -
TitleIndependent DirectorNameLin, Jing-WeiGenderFemaleExperiences/EducationDirector of Great Dream Pictures
CFO of Arrow Cinematic Group
Master of Accounting, NCCU -
TitleIndependent DirectorNameKuo, Ming-YiGenderFemaleExperiences/EducationDirector, KGI Bank Co., Ltd.
Independent Director, Excelsior Medical Co., Ltd.
Consultant of Lexcel Law Offices
Chief of Legal Officer and Compliance Officer, China Development Industrial Bank
Master of Law, Columbia University in the City of New York -
TitleIndependent DirectorNameChen, Chih-KengGenderMaleExperiences/EducationProfessor and heads of department, Vehicle Engineering, NTUT
Vice President, College of Mechanical and Electrical Engineering, NTUT
PhD of Institute of Control engineering, Case Western Reserve University, USA -
TitleIndependent DirectorNameLiu, Wan-YuGenderFemaleExperiences/EducationIndependent Director, Chung Hwa Pulp Corporation
Independent Director, Lion Travel Service Co., Ltd.
Independent Director, CH BioTech R&D Co., Ltd.
Lifetime Distinguished Professor of the Department of Forestry, National Chung Hsing University
PhD of Agricultural Economics, NTU
1.Adoption or amendment of the internal control system pursuant to Article 14-1 of the Securities and Exchange Act.
2.Assessment of the effectiveness of the internal control system.
3.Adoption or amendment of procedures for material financial or operational actions, including the acquisition or disposal of assets, derivative trading, extending loans to others, and providing endorsements or guarantees for others, pursuant to Article 36-1 of the Securities and Exchange Act.
4.Matters involving the personal interests of directors.
5.Material assets or derivative transactions.
6.Material lending of funds, endorsements, or provision of guarantees.
7.The offering, issuance, or private placement of equity-type securities.
8.The appointment, dismissal, or compensation of the external certified public accountant (CPA).
9.The appointment or discharge of financial, accounting, or internal audit executives.
10.Annual financial reports signed or sealed by the Chairman, managerial officers, and accounting officers, and second-quarter financial reports subject to audit and certification by a CPA.
11.Reviewing risk management policies, procedures, and frameworks, and periodically evaluating their suitability and implementation effectiveness; approving risk appetite (risk tolerance) to guide resource allocation; ensuring risk management mechanisms can fully address the risks faced by the company and are integrated into daily operating processes; approving the priorities and levels of risk control; reviewing risk management implementation, providing necessary improvement recommendations, and reporting to the Board of Directors regularly (at least once a year); assisting the Board in supervising the company’s risk management performance.
12.Other material matters as stipulated by the company or the competent authorities.
-
TitleConvenerNameCheng, Wen-JungAttendance in person6Attendance by proxy0Actual attendance rate (%)100%RemarkRe-appointed.
-
TitleIndependent DirectorNameLin, Jing-WeiAttendance in person5Attendance by proxy1Actual attendance rate (%)83%RemarkRe-appointed.
-
TitleIndependent DirectorNameKuo, Ming-YiAttendance in person6Attendance by proxy0Actual attendance rate (%)100%RemarkRe-appointed.
-
TitleIndependent DirectorNameChen, Chih-KengAttendance in person6Attendance by proxy0Actual attendance rate (%)100%RemarkRe-appointed.
-
TitleIndependent DirectorNameLiu, Wan-YuAttendance in person2Attendance by proxy0Actual attendance rate (%)100%RemarkNew appointed
-
Date2026/08/12Proposal Content1.The financial statements of Q2 2026.ResolutionPassedThe Company’s Response to Opinions Expressed by the Audit and Risk Management CommitteeNo opinion, not applicable.
-
Date2026/05/27Proposal ContentProposal for the Election of the Convener and Meeting Chair of the Audit and Risk Management CommitteeResolutionIndependent Director, Cheng, Wen-Jung was elected as the Convenet and Meeting Chair.The Company’s Response to Opinions Expressed by the Audit and Risk Management CommitteeNo opinion, not applicable.
-
Date2026/05/13Proposal Content1.The financial statements of Q1 2026.
2.Proposal for the Amendment to the Company's Guidelines on Risk Appetite Levels, Ratings, and Response Strategies.ResolutionPassedThe Company’s Response to Opinions Expressed by the Audit and Risk Management CommitteeNo opinion, not applicable. -
Date2026/04/13Proposal Content1.The proposal for distribution of earnings in 2025.
2.the proposal for distribution of cash dividend.ResolutionPassedThe Company’s Response to Opinions Expressed by the Audit and Risk Management CommitteeNo opinion, not applicable. -
Date2026/03/11Proposal Content1.The financial statements of 2025.
2.The amendment of the Company's Endorsement and Guarantee Procedures.
3.The amendment of the Company's Procedures for Lending Funds to Others.
4.The amendment of the Company's Procedures for Acquiring or Disposing of Assets.
5.The amendment of the Company's Procedures for Engaging in Derivatives Trading.
6.The Declaration of the Internal Control System in 2025.
7.The evaluation of the independence of CPAs and appointment.ResolutionPassedThe Company’s Response to Opinions Expressed by the Audit and Risk Management CommitteeNo opinion, not applicable. -
Date202/01/20Proposal ContentThe equity investment in Belgium Magnax BV.ResolutionPassed, and authorized the Chairman with full power to handle related matters.The Company’s Response to Opinions Expressed by the Audit and Risk Management CommitteeNo opinion, not applicable.